Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
α-Dicarbonyl compounds are reactive organic molecules characterized by the presence of two carbonyl (C=O) groups on adjacent carbon atoms. Examples include methylglyoxal, glyoxal, and diacetyl. They are highly electrophilic, readily reacting with nucleophilic amino acid side chains (notably lysine and arginine) to form advanced glycation end-products (AGEs), which accumulate in aging tissues and in chronic diseases like diabetes and kidney disease[2][4][5][6][8]. In food chemistry, they arise as intermediates in the Maillard reaction—contributing to flavor and color in cooked foods but also acting as precursors to potentially hazardous substances[3][8]. Due to their rapid and irreversible modification of proteins and other macromolecules, α-dicarbonyl compounds are linked to biological damage and are studied as both biomarkers and pathogenic mediators in metabolic and age-related diseases.
Trapping of α-dicarbonyls to prevent AGE formation (by nucleophilic drugs)[5][2] Inhibition of Maillard reaction or dicarbonyl-mediated protein modification
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on α-Dicarbonyl compound.